Correlation Between Timber Pharmaceuticals and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Timber Pharmaceuticals and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Timber Pharmaceuticals and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Timber Pharmaceuticals and X4 Pharmaceuticals, you can compare the effects of market volatilities on Timber Pharmaceuticals and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Timber Pharmaceuticals with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Timber Pharmaceuticals and X4 Pharmaceuticals.
Diversification Opportunities for Timber Pharmaceuticals and X4 Pharmaceuticals
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Timber and XFOR is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Timber Pharmaceuticals and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Timber Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Timber Pharmaceuticals are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Timber Pharmaceuticals i.e., Timber Pharmaceuticals and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Timber Pharmaceuticals and X4 Pharmaceuticals
If you would invest 52.00 in X4 Pharmaceuticals on September 2, 2024 and sell it today you would lose (13.00) from holding X4 Pharmaceuticals or give up 25.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 4.76% |
Values | Daily Returns |
Timber Pharmaceuticals vs. X4 Pharmaceuticals
Performance |
Timeline |
Timber Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
X4 Pharmaceuticals |
Timber Pharmaceuticals and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Timber Pharmaceuticals and X4 Pharmaceuticals
The main advantage of trading using opposite Timber Pharmaceuticals and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Timber Pharmaceuticals position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.Timber Pharmaceuticals vs. Salarius Pharmaceuticals | Timber Pharmaceuticals vs. Nutriband | Timber Pharmaceuticals vs. Aileron Therapeutics | Timber Pharmaceuticals vs. Artelo Biosciences |
X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |